MEDS - Trxade Group Inc Stock Price, Fair Value and News

$0.55-0.05 (-8.33%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

MEDS Price Action

Last 7 days

13.2%

Last 30 days

-34.1%

Last 90 days

-38.8%

Trailing 12 Months

-92.3%

MEDS RSI Chart

MEDS Valuation

Market Cap

22.3M

Price/Earnings (Trailing)

-1.09

Price/Sales (Trailing)

20.62

EV/EBITDA

-1.66

Price/Free Cashflow

-2.7

MEDS Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

MEDS Fundamentals

MEDS Revenue

Revenue (TTM)

1.5M

Rev. Growth (Yr)

809.71%

Rev. Growth (Qtr)

-30.71%

MEDS Earnings

Earnings (TTM)

-20.6M

Earnings Growth (Yr)

-13.31%

Earnings Growth (Qtr)

46.32%

MEDS Profitability

Operating Margin

99.84%

EBT Margin

-1421.42%

Return on Equity

-24.86%

Return on Assets

-19.61%

Free Cashflow Yield

-37.01%

MEDS Investor Care

Shares Dilution (1Y)

373.73%

Diluted EPS (TTM)

-9.88

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2025	0	0	0	0
2024	0	1.1M	1.3M	1.5M
2023	7.5M	6.5M	4.5M	875.1K
2022	10.1M	11.5M	11.3M	10.3M
2021	18.0M	13.3M	9.5M	9.9M
2020	8.1M	12.8M	16.8M	17.1M
2019	4.5M	5.6M	7.0M	7.4M
2018	3.1M	3.2M	3.3M	3.8M
2017	2.8M	2.9M	3.0M	3.0M
2016	2.4M	2.7M	3.0M	3.2M
2015	1.9M	2.8M	4.1M	2.1M
2014	1.1M	1.2M	1.4M	1.5M
2013	0	0	0	955.9K

Get all data in R, Python etc through our Historical Stock Data APIs

About Trxade Group Inc

TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which offers price transparency, purchasing capabilities, and other value-added services; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Lutz, Florida.

CEO	Mr. Surendra K. Ajjarapu
WEBSITE	trxadehealth.com
SECTOR	Healthcare
INDUSTRY	Pharmaceutical Retailers
EMPLOYEES	33

Trxade Group Inc Frequently Asked Questions

What is the ticker symbol for Trxade Group Inc? What does MEDS stand for in stocks?

MEDS is the stock ticker symbol of Trxade Group Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Trxade Group Inc (MEDS)?

As of Mon Dec 01 2025, market cap of Trxade Group Inc is 22.35 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of MEDS stock?

You can check MEDS's fair value in chart for subscribers.

Is Trxade Group Inc a good stock to buy?

The fair value guage provides a quick view whether MEDS is over valued or under valued. Whether Trxade Group Inc is cheap or expensive depends on the assumptions which impact Trxade Group Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MEDS.

What is Trxade Group Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon Dec 01 2025, MEDS's PE ratio (Price to Earnings) is -1.09 and Price to Sales (PS) ratio is 20.62. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MEDS PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Trxade Group Inc's stock?

In the past 10 years, Trxade Group Inc has provided -0.401 (multiply by 100 for percentage) rate of return.